silvia clara giliani

Prof. silvia clara giliani

orcid

Research Focus & Metrics

Academic Career Length

23Years (2004-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
24 August 2018 in Journal of Experimental Medicine
Verified
Journal Article
Open access
PDF file
NHNicholas Hernandez
Nicholas Hernandez
IMIsabelle Melki
Isabelle Melki
HJHuie Jing
Huie Jing
THTanwir Habib
Tanwir Habib
SHSusie S.Y. Huang
Susie S.Y. Huang
JCJean-Laurent Casanova
Jean-Laurent Casanova
Life-threatening pulmonary influenza can be caused by inborn errors of type I and III IFN immunity. We report a 5-yr-old child with severe pulmonary influenza at 2 yr. She is homozygous for a loss-of-function IRF9 allele. Her cells activate gamma-activated factor (GAF) STAT1 homodimers but not IFN-stimulated gene factor 3 (ISGF3) trimers (STAT1/STAT2/IRF9) in response to IFN-α2b. The transcriptome induced by IFN-α2b in the patient’s cells is much narrower than that of control cells; however, induction of a subset of IFN-stimulated gene transcripts remains detectable. In vitro, the patient’s cells do not control three respiratory viruses, influenza A virus (IAV), parainfluenza virus (PIV), and respiratory syncytial virus (RSV). These phenotypes are rescued by wild-type IRF9, whereas silencing IRF9 expression in control cells increases viral replication. However, the child has controlled various common viruses in vivo, including respiratory viruses other than IAV. Our findings show that human IRF9- and ISGF3-dependent type I and III IFN responsive pathways are essential for controlling IAV.

1 June 2004 in The Lancet
Verified
Journal Article
Closed access
CLCaroline Laffort
Caroline Laffort
FDFrançoise Le Deist
Françoise Le Deist
MFMichel Favre
Michel Favre
SCSophie Caillat-Zucman
Sophie Caillat-Zucman
IRIsabelle Radford-Weiss
Isabelle Radford-Weiss
MDMarianne Debré
Marianne Debré

14 February 2020 in Science Immunology
Verified
Journal Article
Closed access
YYYasuhiro Yamazaki
Yasuhiro Yamazaki
RURaul A. Urrutia
Raul A. Urrutia
LFLuis M. Franco
Luis M. Franco
SGsilvia clara giliani
silvia clara giliani
KZKejian Zhang
Kejian Zhang
LNLuigi Daniele Notarangelo
Luigi Daniele Notarangelo
PAX1deficiency causes a syndromic form of SCID by altering differentiation of thymic epithelial cells and other pharyngeal pouch tissues.

1 February 2017 in Journal of Experimental Medicine
Verified
Journal Article
Open access
PDF file
SVstefano volpi
stefano volpi
YYYasuhiro Yamazaki
Yasuhiro Yamazaki
PBPatrick M. Brauer
Patrick M. Brauer
EREllen van Rooijen
Ellen van Rooijen
AHAtsuko Hayashida
Atsuko Hayashida
LNLuigi Daniele Notarangelo
Luigi Daniele Notarangelo
We studied three patients with severe skeletal dysplasia, T cell immunodeficiency, and developmental delay. Whole-exome sequencing revealed homozygous missense mutations affecting exostosin-like 3 (EXTL3), a glycosyltransferase involved in heparan sulfate (HS) biosynthesis. Patient-derived fibroblasts showed abnormal HS composition and altered fibroblast growth factor 2 signaling, which was rescued by overexpression of wild-type EXTL3 cDNA. Interleukin-2–mediated STAT5 phosphorylation in patients’ lymphocytes was markedly reduced. Interbreeding of the extl3-mutant zebrafish (box) with Tg(rag2:green fluorescent protein) transgenic zebrafish revealed defective thymopoiesis, which was rescued by injection of wild-type human EXTL3 RNA. Targeted differentiation of patient-derived induced pluripotent stem cells showed a reduced expansion of lymphohematopoietic progenitor cells and defects of thymic epithelial progenitor cell differentiation. These data identify EXTL3 mutations as a novel cause of severe immune deficiency with skeletal dysplasia and developmental delay and underline a crucial role of HS in thymopoiesis and skeletal and brain development.

9 March 2022 in Journal of Experimental Medicine
Verified
Journal Article
Open access
PDF file
AGAnna Maria Sole Giordano
Anna Maria Sole Giordano
MLMarco Luciani
Marco Luciani
FGFrancesca Gatto
Francesca Gatto
MAMonah Abou Alezz
Monah Abou Alezz
CBChiara Beghè
Chiara Beghè
AKAnna Kajaste-Rudnitski
Anna Kajaste-Rudnitski
Aberrant induction of type I IFN is a hallmark of the inherited encephalopathy Aicardi-Goutières syndrome (AGS), but the mechanisms triggering disease in the human central nervous system (CNS) remain elusive. Here, we generated human models of AGS using genetically modified and patient-derived pluripotent stem cells harboring TREX1 or RNASEH2B loss-of-function alleles. Genome-wide transcriptomic analysis reveals that spontaneous proinflammatory activation in AGS astrocytes initiates signaling cascades impacting multiple CNS cell subsets analyzed at the single-cell level. We identify accumulating DNA damage, with elevated R-loop and micronuclei formation, as a driver of STING- and NLRP3-related inflammatory responses leading to the secretion of neurotoxic mediators. Importantly, pharmacological inhibition of proapoptotic or inflammatory cascades in AGS astrocytes prevents neurotoxicity without apparent impact on their increased type I IFN responses. Together, our work identifies DNA damage as a major driver of neurotoxic inflammation in AGS astrocytes, suggests a role for AGS gene products in R-loop homeostasis, and identifies common denominators of disease that can be targeted to prevent astrocyte-mediated neurotoxicity in AGS.

7 December 2020 in Materials
Verified
Journal Article
Open access
PDF file
PGPaola Ginestra
Paola Ginestra
RFRosalba Monica Ferraro
Rosalba Monica Ferraro
KZKeren Zohar-Hauber
Keren Zohar-Hauber
AAAndrea Abeni
Andrea Abeni
SGsilvia clara giliani
silvia clara giliani
ECElisabetta Ceretti
Elisabetta Ceretti
The 3D printing process offers several advantages to the medical industry by producing complex and bespoke devices that accurately reproduce customized patient geometries. Despite the recent developments that strongly enhanced the dominance of additive manufacturing (AM) techniques over conventional methods, processes need to be continually optimized and controlled to obtain implants that can fulfill all the requirements of the surgical procedure and the anatomical district of interest. The best outcomes of an implant derive from optimal compromise and balance between a good interaction with the surrounding tissue through cell attachment and reduced inflammatory response mainly caused by a weak interface with the native tissue or bacteria colonization of the implant surface. For these reasons, the chemical, morphological, and mechanical properties of a device need to be designed in order to assure the best performances considering the in vivo environment components. In particular, complex 3D geometries can be produced with high dimensional accuracy but inadequate surface properties due to the layer manufacturing process that always entails the use of post-processing techniques to improve the surface quality, increasing the lead times of the whole process despite the reduction of the supply chain. The goal of this work was to provide a comparison between Ti6Al4V samples fabricated by selective laser melting (SLM) and electron beam melting (EBM) with different building directions in relation to the building plate. The results highlighted the influence of the process technique on osteoblast attachment and mineralization compared with the building orientation that showed a limited effect in promoting a proper osseointegration over a long-term period.